Although the overexpression of different genes belonging to the MYC family has been considered as mutually exclusive in different SCLC subtypes (Bragelmann et al, 2017), the high specificity of lurbinectedin enabled a prompt downregulation on the overall MYC family of oncogenes in different SCLC cellular backgrounds. This evidence concerns the gene MYC and small cell lung carcinoma.